title: Vision loss following denileukin diftitox treatment: a case report of possible posterior ischemic optic neuropathy.
authors: Meyeon
authors: M
authors: Park
authors: Grant T
authors: GT
authors: Liu
authors: Jody
authors: J
authors: Piltz-Seymour
authors: Catherine L
authors: CL
authors: Wisda
authors: Alain H
authors: AH
authors: Rook
authors: Jacqueline M
authors: JM
authors: Junkins-Hopkins
authors: Sunita D
authors: SD
authors: Nasta
authors: Ellen J
authors: EJ
authors: Kim
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004167:Diphtheria Toxin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D016399:Lymphoma, T-Cell / Q000188:drug therapy*; D018917:Optic Neuropathy, Ischemic / Q000139:chemically induced* / Q000175:diagnosis*; D011993:Recombinant Fusion Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012074:Remission Induction; D012307:Risk Factors; D012878:Skin Neoplasms / Q000188:drug therapy*; D014786:Vision Disorders / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents; D004167:Diphtheria Toxin; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; C078456:denileukin diftitox